Lisanti Capital Growth Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
+$7.26M |
| 2 |
Ollie's Bargain Outlet
OLLI
|
+$6.35M |
| 3 |
CareDx
CDNA
|
+$6.35M |
| 4 |
Cloudflare
NET
|
+$5.7M |
| 5 |
Lattice Semiconductor
LSCC
|
+$5.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIVE9
FIVN
|
+$9.22M |
| 2 |
FTI Consulting
FCN
|
+$6.26M |
| 3 |
Itron
ITRI
|
+$6.25M |
| 4 |
Repligen
RGEN
|
+$6.07M |
| 5 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
+$5.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.1% |
| 2 | Technology | 20.72% |
| 3 | Industrials | 19.83% |
| 4 | Consumer Discretionary | 16.89% |
| 5 | Financials | 6.07% |
Similar funds
Lisanti Capital Growth's Q2 2020 Portfolio in Review
As of Q2 2020, Lisanti Capital Growth held 156 positions worth $491M, up 62% from $303M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Lisanti Capital Growth deployed $45.5M of net new capital in Q2 2020, opening 44 new positions and adding to 44 existing holdings. Its largest new stake was Livongo Health, Inc. Common Stock: 138,705 shares worth $10.4M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was FIVE9, an estimated $9.22M trimmed.
- Lisanti Capital Growth's largest Q2 2020 buy was Livongo Health, Inc. Common Stock: 138,705 shares worth $10.4M.
- Lisanti Capital Growth added most to Patrick Industries in Q2 2020, an estimated $4.65M increase.
- Lisanti Capital Growth's biggest Q2 2020 reduction was FIVE9, cutting an estimated $9.22M.
- Lisanti Capital Growth fully exited FTI Consulting in Q2 2020, selling an estimated $6.26M.
- Lisanti Capital Growth's ten largest holdings make up 19% of its $491M portfolio in Q2 2020.
- Lisanti Capital Growth opened 44 new positions and closed 39 in Q2 2020.
- Lisanti Capital Growth's portfolio value rose 62% quarter-over-quarter to $491M.
Based on Lisanti Capital Growth's 13F filing for Q2 2020, filed 10 Aug 2020.